PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,958 | -37.5% | 3,406 | -16.1% | 0.00% | – |
| Q2 2023 | $14,332 | -57.5% | 4,060 | -62.8% | 0.00% | – |
| Q1 2023 | $33,758 | +132.0% | 10,925 | +217.6% | 0.00% | – |
| Q4 2022 | $14,551 | +81.9% | 3,440 | +0.4% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 3,425 | -24.5% | 0.00% | – |
| Q2 2022 | $13,000 | -82.7% | 4,539 | -82.5% | 0.00% | – |
| Q1 2022 | $75,000 | +41.5% | 25,985 | +48.8% | 0.00% | – |
| Q4 2021 | $53,000 | +15.2% | 17,462 | +167.7% | 0.00% | – |
| Q3 2021 | $46,000 | -51.1% | 6,524 | -36.6% | 0.00% | – |
| Q2 2021 | $94,000 | -83.1% | 10,285 | -82.1% | 0.00% | – |
| Q1 2021 | $557,000 | +486.3% | 57,336 | +517.3% | 0.00% | – |
| Q4 2020 | $95,000 | -94.1% | 9,288 | -94.2% | 0.00% | -100.0% |
| Q3 2020 | $1,604,000 | -3.5% | 158,958 | -0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,663,000 | +19.8% | 159,489 | -3.0% | 0.00% | 0.0% |
| Q1 2020 | $1,388,000 | +877.5% | 164,497 | +917.1% | 0.00% | – |
| Q4 2019 | $142,000 | -94.5% | 16,173 | -93.2% | 0.00% | -100.0% |
| Q3 2019 | $2,571,000 | +1328.3% | 238,788 | +1586.2% | 0.00% | – |
| Q2 2019 | $180,000 | -81.7% | 14,161 | -44.1% | 0.00% | – |
| Q1 2019 | $982,000 | -74.9% | 25,319 | -86.8% | 0.00% | -100.0% |
| Q4 2018 | $3,914,000 | +43.1% | 192,309 | +222.4% | 0.00% | +100.0% |
| Q3 2018 | $2,735,000 | +13.4% | 59,646 | +46.3% | 0.00% | 0.0% |
| Q2 2018 | $2,411,000 | -50.4% | 40,768 | -42.9% | 0.00% | -50.0% |
| Q1 2018 | $4,862,000 | -74.4% | 71,451 | -62.9% | 0.00% | -75.0% |
| Q4 2017 | $19,027,000 | +244.5% | 192,480 | +317.4% | 0.01% | +166.7% |
| Q3 2017 | $5,523,000 | +5.1% | 46,118 | -23.3% | 0.00% | 0.0% |
| Q2 2017 | $5,255,000 | +91.4% | 60,126 | -18.5% | 0.00% | +200.0% |
| Q1 2017 | $2,745,000 | -46.6% | 73,784 | -55.9% | 0.00% | -66.7% |
| Q4 2016 | $5,137,000 | -32.4% | 167,317 | +47.6% | 0.00% | -40.0% |
| Q3 2016 | $7,602,000 | +79.8% | 113,378 | -20.1% | 0.01% | +66.7% |
| Q2 2016 | $4,229,000 | +17.8% | 141,970 | +16.2% | 0.00% | +50.0% |
| Q1 2016 | $3,589,000 | -54.2% | 122,209 | +22.4% | 0.00% | -60.0% |
| Q4 2015 | $7,829,000 | -37.1% | 99,858 | -39.5% | 0.01% | -44.4% |
| Q3 2015 | $12,438,000 | -33.1% | 165,049 | +3.7% | 0.01% | -25.0% |
| Q2 2015 | $18,583,000 | -39.7% | 159,175 | +22.0% | 0.01% | -45.5% |
| Q1 2015 | $30,807,000 | +283.1% | 130,478 | +207.1% | 0.02% | +340.0% |
| Q4 2014 | $8,041,000 | – | 42,488 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |